# TriSalus Life Sciences, Inc. (TLSI) MD&A by fiscal year

Verbatim Item 7 Management's Discussion and Analysis sections from TriSalus Life Sciences, Inc.'s 10-K filings, one page per fiscal year. Extracted from SEC filings with the same bounded parser for every year. Filer text, not grepcent analysis or investment advice.

- [FY 2025 MD&A](/company/TLSI/mda/fy2025/): filed 2026-03-05; accession 0001628280-26-015163 (https://www.sec.gov/Archives/edgar/data/1826667/000162828026015163/tlsi-20251231.htm); latest 10-K
- [FY 2024 MD&A](/company/TLSI/mda/fy2024/): filed 2025-04-15; accession 0001826667-25-000030 (https://www.sec.gov/Archives/edgar/data/1826667/000182666725000030/tlsi-20241231.htm)
- [FY 2023 MD&A](/company/TLSI/mda/fy2023/): filed 2024-04-11; accession 0001826667-24-000005 (https://www.sec.gov/Archives/edgar/data/1826667/000182666724000005/tlsi-20231231.htm)
- [FY 2022 MD&A](/company/TLSI/mda/fy2022/): filed 2023-03-22; accession 0001410578-23-000332 (https://www.sec.gov/Archives/edgar/data/1826667/000141057823000332/mtac-20221231x10k.htm)
- [FY 2021 MD&A](/company/TLSI/mda/fy2021/): filed 2022-03-03; accession 0001410578-22-000252 (https://www.sec.gov/Archives/edgar/data/1826667/000141057822000252/mtac-20211231x10k.htm)

Back to /company/TLSI/